Avastin cancer drug timeline:
"1997: Genentech begins clinical trials of Avastin on cancer patients.
February 2004: FDA approves Avastin to treat colon cancer.
October 2006: FDA approves Avastin to treat lung cancer.
December 2007: Advisory committee votes 5-4 against FDA approval of Avastin for breast cancer treatment.
February 2008: FDA ignores recommendation, grants accelerated temporary approval for use of Avastin in treating breast cancer.
May 2009: FDA approves Avastin to treat brain cancer.
July 2009: FDA approves Avastin to treat kidney cancer.
July 20, 2010: Advisory committee votes 12-1 against permanent FDA approval for use of Avastin against breast cancer.
Sept. 17: The FDA is scheduled to make a final decision on use of Avastin as a breast cancer treatment.
- Sent using Google Toolbar"
No comments:
Post a Comment